Plus Pharma Senna

Product NDC: 51645-851
Requested package NDC: 51645-851-01
11-digit product format: 516450851
Labeler code: 51645
Product ID: 51645-851_b3db67aa-c0c4-6f75-e053-2a95a90a6d72
Type: HUMAN OTC DRUG
Nonproprietary name: SENNOSIDES
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Gemini Pharmaceuticals, Inc. dba Plus Pharma
Application: part334
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2006-03-27
Marketing end: 0000-00-00
Substance: SENNOSIDES
Active strength: 9 mg/1
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	51645-851	51645-851-01	D	Discontinued by firm		2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
51645-851-10	EA - Each	51645-851	ec774260-08e4-4076-8a87-d96c3a929024	1	2021-11-09
51645-851-99	EA - Each	51645-851	8f93eb26-17ef-46d5-b2d2-63cd91fa3c7a	1	2016-03-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
SENNOSIDES	ACTIVE INGREDIENT	3FYP5M0IJX	PLUS PHARMA SENNA STANDARDIZED SENNA CONCENTRATE 8.6 MG SENNOSIDES EACH (SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	3
SENNOSIDES	ACTIVE MOIETY	3FYP5M0IJX	PLUS PHARMA SENNA STANDARDIZED SENNA CONCENTRATE 8.6 MG SENNOSIDES EACH (SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	3
ACACIA	INACTIVE INGREDIENT	5C5403N26O	PLUS PHARMA SENNA STANDARDIZED SENNA CONCENTRATE 8.6 MG SENNOSIDES EACH (SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	3
CALCIUM CARBONATE	INACTIVE INGREDIENT	H0G9379FGK	PLUS PHARMA SENNA STANDARDIZED SENNA CONCENTRATE 8.6 MG SENNOSIDES EACH (SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	PLUS PHARMA SENNA STANDARDIZED SENNA CONCENTRATE 8.6 MG SENNOSIDES EACH (SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	3
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	PLUS PHARMA SENNA STANDARDIZED SENNA CONCENTRATE 8.6 MG SENNOSIDES EACH (SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	3
DEXTROSE	INACTIVE INGREDIENT	IY9XDZ35W2	PLUS PHARMA SENNA STANDARDIZED SENNA CONCENTRATE 8.6 MG SENNOSIDES EACH (SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	3
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	PLUS PHARMA SENNA STANDARDIZED SENNA CONCENTRATE 8.6 MG SENNOSIDES EACH (SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	PLUS PHARMA SENNA STANDARDIZED SENNA CONCENTRATE 8.6 MG SENNOSIDES EACH (SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	3
MALTODEXTRIN	INACTIVE INGREDIENT	7CVR7L4A2D	PLUS PHARMA SENNA STANDARDIZED SENNA CONCENTRATE 8.6 MG SENNOSIDES EACH (SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	3
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	PLUS PHARMA SENNA STANDARDIZED SENNA CONCENTRATE 8.6 MG SENNOSIDES EACH (SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	3
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	PLUS PHARMA SENNA STANDARDIZED SENNA CONCENTRATE 8.6 MG SENNOSIDES EACH (SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	3
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	PLUS PHARMA SENNA STANDARDIZED SENNA CONCENTRATE 8.6 MG SENNOSIDES EACH (SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	3
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	PLUS PHARMA SENNA STANDARDIZED SENNA CONCENTRATE 8.6 MG SENNOSIDES EACH (SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	3
SENNOSIDES A AND B	ACTIVE INGREDIENT	1B5FPI42EN	SENNA PLUS TABLET [REBEL DISTRIBUTORS CORP]	1
SENNOSIDES	ACTIVE MOIETY	3FYP5M0IJX	SENNA PLUS TABLET [REBEL DISTRIBUTORS CORP]	1

UNII, Preferred term, Matched term table
UNII	Preferred term	Matched term
3FYP5M0IJX	SENNOSIDES	SENNOSIDES

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
312935	sennosides 8.6 MG Oral Tablet	PSN	5bbcb8c2-16e9-4b98-b75e-4f72a2480564	3
312935	sennosides, USP 8.6 MG Oral Tablet	SCD	5bbcb8c2-16e9-4b98-b75e-4f72a2480564	3
312935	sennosides A and B 8.6 MG Oral Tablet	SY	5bbcb8c2-16e9-4b98-b75e-4f72a2480564	3
312935	sennosides 8.6 MG Oral Tablet	PSN	5b17afd8-de62-4684-b556-d2846eb214b8	1
312935	sennosides 8.6 MG Oral Tablet	PSN	9af0e21e-0667-4c83-e053-2995a90a2f0f	1
312935	sennosides, USP 8.6 MG Oral Tablet	SCD	5b17afd8-de62-4684-b556-d2846eb214b8	1
312935	sennosides, USP 8.6 MG Oral Tablet	SCD	9af0e21e-0667-4c83-e053-2995a90a2f0f	1
312935	sennosides A and B 8.6 MG Oral Tablet	SY	5b17afd8-de62-4684-b556-d2846eb214b8	1
312935	sennosides A and B 8.6 MG Oral Tablet	SY	9af0e21e-0667-4c83-e053-2995a90a2f0f	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
51645-851-01	51645085101	100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51645-851-01)	2006-03-27	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Drug Facts	NuCare Pharmaceuticals,Inc.	2021-01-11	HUMAN OTC DRUG LABEL	2
Senna Tablets	Gemini Pharmaceuticals, Inc. dba Plus Pharma	2020-11-11	HUMAN OTC DRUG LABEL	6
Senna Tablets	medsource pharmaceuticals	2019-12-30	HUMAN OTC DRUG LABEL	1
Senna Tablets	medsource pharmaceuticals	2019-12-30	HUMAN OTC DRUG LABEL	1
Drug Facts	Proficient Rx LP	2019-11-01	HUMAN OTC DRUG LABEL	3
Senna Plus Drug Facts	Rebel Distributors Corp	2011-09-07	HUMAN OTC DRUG LABEL	1
Drug Facts	Unit Dose Services	2006-03-27	HUMAN OTC DRUG LABEL	3